About Bartec Technologies
Bartec Technologies is a company based in Farnborough (United Kingdom) founded in 1998 was acquired by Mediso in May 2022. Bartec Technologies offers products and services including AnyScan® TRIO SPECT/CT, nanoScan® PET/MRI, nanoScan® SPECT/CT, and nanoScan® PET/CT. Bartec Technologies operates in a competitive market with competitors including Cardinal Health, CNX Therapeutics, Concordia International, Xiel and SPL Pharma, among others.
- Headquarter Farnborough, United Kingdom
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Mediso Medical Imaging Systems Uk Limited
- Date of Incorporation 17 Aug, 1998
- Jurisdiction FARNBOROUGH, HAMPSHIRE, ENGLAND
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bartec Technologies
Bartec Technologies offers a comprehensive portfolio of products and services, including AnyScan® TRIO SPECT/CT, nanoScan® PET/MRI, nanoScan® SPECT/CT, and nanoScan® PET/CT.
SPECT/CT for theragnostic and diagnostic imaging in clinical settings
PET/MRI for quantitative preclinical research and molecular imaging
SPECT/CT for absolute quantification in preclinical applications
PET/CT for real dynamic studies in research environments
Funding Insights of Bartec Technologies
Detailed funding history for Bartec Technologies
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Bartec Technologies
Bartec Technologies has secured backing from 1 investor. Prominent investors backing the company include Mediso.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Nuclear medicine and hybrid imaging equipment
|
Locked | Locked | Locked |
Investor details for Bartec Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bartec Technologies
Investment portfolio details for Bartec Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bartec Technologies
Detailed financials for Bartec Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bartec Technologies Comparisons
Peer comparison for Bartec Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bartec Technologies
Bartec Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cardinal Health, CNX Therapeutics, Concordia International, Xiel and SPL Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Multiple healthcare products and services are provided to organizations.
|
|
| Locked | Locked | Locked |
Distributor of specialty drugs
|
|
| Locked | Locked | Locked |
Distributes specialty pharmaceutical drugs to healthcare providers.
|
|
| Locked | Locked | Locked |
Specialist nuclear medicine and radiotherapy solutions are distributed.
|
|
| Locked | Locked | Locked |
International distribution of specialty medicines and pharmaceutical market access services.
|
Detailed competitors of Bartec Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bartec Technologies
Complete news archive for Bartec Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bartec Technologies
Bartec Technologies was founded in 1998.
Bartec Technologies is headquartered in Farnborough, United Kingdom. It is registered at Farnborough, Hampshire, United Kingdom.
Founded in 1998 and based in Farnborough, United Kingdom, Bartec Technologies operates in the medical imaging sector. Clinical and preclinical molecular imaging systems are provided, along with modality-specific detectors for nuclear medicine applications. Radioactive sources, including flood sources and phantoms, are offered for quality control. Radiation protection services, such as lead-lined shielding, are also supplied to support healthcare environments. Operations focus on diagnostic and therapeutic tools across various institutions.
Bartec Technologies's top competitors include Cardinal Health, Xiel and CNX Therapeutics.
Bartec Technologies offers AnyScan® TRIO SPECT/CT, nanoScan® PET/MRI, nanoScan® SPECT/CT, and nanoScan® PET/CT.
Bartec Technologies has 1 investor. Key investors include Mediso.